- Filed
- Dec 16, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 16, 2024 | 4.9M sh |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $5.45M |
| Cash And Equivalents | Q2 2025 · Apr 30, 2024 | $7.11M |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $5.32M |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $3.76M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $7.98M |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $6.14M |
| Current Assets | Q2 2025 · Oct 31, 2024 | $59.67M |
| Current Assets | Q2 2025 · Apr 30, 2024 | $57.44M |
| Total Assets | Q2 2025 · Oct 31, 2024 | $62.79M |
| Total Assets | Q2 2025 · Apr 30, 2024 | $60.78M |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 4.93M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 4.95M sh |
| Dividends Paid | Q2 2025 · Oct 31, 2023 | $2.91M |
| Capex | Q2 2025 · Oct 31, 2023 | $243K |
| Operating Cash Flow | Q2 2025 · Oct 31, 2023 | $1.56M |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $49.49M |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $52.98M |
| Stockholders Equity | Q2 2025 · Apr 30, 2023 | $50.65M |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | −$0.01 |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | $0.47 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | −$0.01 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | $0.47 |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $333K |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $702K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$55K |
| Net Income | Q2 2025 · Oct 31, 2023 | $2.32M |
| Operating Income | Q2 2025 · Oct 31, 2023 | $1.97M |
| Operating Income | Q2 2025 · Oct 31, 2023 | $3.16M |
| Gross Profit | Q2 2025 · Oct 31, 2023 | $3.1M |
| Gross Profit | Q2 2025 · Oct 31, 2023 | $5.37M |
| Cost Of Revenue | Q2 2025 · Oct 31, 2023 | $2.95M |
| Cost Of Revenue | Q2 2025 · Oct 31, 2023 | $5.41M |
| Revenue | Q2 2025 · Oct 31, 2023 | $6.05M |
| Revenue | Q2 2025 · Oct 31, 2023 | $10.78M |